Crop Innovation Using Sequence Based Genotyping
Crop Innovation Using Sequence Based Genotyping
Date: Monday, January 16, 2017
Time: 1:10 PM
Time: 1:10 PM
Room: Royal Palm Salon 3-4
Next Generation Sequencing has revolutionized the life sciences including crop improvement. Over the past decade KeyGene has leveraged the power of NGS in its Accelerated Molecular Breeding platform to develop a portfolio of proprietary Sequence Based Genotyping approaches suiting the needs of today's molecular plant breeders in terms of quality, cost, flexibility and turn-around times.
Sequence-Based Genotyping (SBG) technology enables simultaneous discovery and genotyping of novel polymorphisms in any germplasm using restriction enzyme-mediated complexity reduction approaches; at present many forms of SBG including GBS, RAD-Seq and related methods are widely used for crop genotyping. KeyGene® SNPSelect is complementary to SBG as it provides a fully customizable, highly flexible NGS-based targeted genotyping solution for preselected polymorphisms at unparalleled scale and competitive cost per data-point. Our whole genome re-sequencing approaches in combination with fast variant detection enable high resolution analysis of germplasm including detection of rare variants.
Sequence-Based Genotyping (SBG) technology enables simultaneous discovery and genotyping of novel polymorphisms in any germplasm using restriction enzyme-mediated complexity reduction approaches; at present many forms of SBG including GBS, RAD-Seq and related methods are widely used for crop genotyping. KeyGene® SNPSelect is complementary to SBG as it provides a fully customizable, highly flexible NGS-based targeted genotyping solution for preselected polymorphisms at unparalleled scale and competitive cost per data-point. Our whole genome re-sequencing approaches in combination with fast variant detection enable high resolution analysis of germplasm including detection of rare variants.
Based on these methods, KeyGene offers tailor-made solutions to all plant breeder's genotyping needs.
The SBG and KeyGene® SNPSelect technologies are protected by patents and patent applications owned by KeyGene N.V..
